MedPath

APO-MONTELUKAST SODIUM

APO-MONTELUKAST SODIUM

Approved
DIN Number

02517329

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02517329
AIG Number0163009002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03DC03 MONTELUKAST
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:10.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

MONTELUKAST SODIUMActive
Strength: 10 MG
Monograph: MONTELUKAST SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.